Based on Nature ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  7.1% 7.1% 7.1% 7.1% 7.1%  
Bankruptcy risk  27.9% 19.8% 9.1% 27.3% 11.2%  
Credit score (0-100)  2 5 26 1 22  
Credit rating  B B BB B BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -158 -9.8 89.7 -42.1 131  
EBITDA  -158 -9.8 88.1 -42.1 131  
EBIT  -160 -65.0 3.9 -125 88.7  
Pre-tax profit (PTP)  -159.8 -70.9 2.2 -127.2 85.7  
Net earnings  -159.8 -70.9 2.2 -127.2 85.7  
Pre-tax profit without non-rec. items  -160 -70.9 2.2 -127 85.7  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  24.1 285 280 148 0.0  
Shareholders equity total  -120 -191 -188 -318 -232  
Interest-bearing liabilities  29.2 388 388 172 5.0  
Balance sheet total (assets)  81.5 481 495 170 135  

Net Debt  4.6 327 206 156 -130  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -158 -9.8 89.7 -42.1 131  
Gross profit growth  0.0% 93.8% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  81 481 495 170 135  
Balance sheet change%  0.0% 490.9% 2.9% -65.7% -20.8%  
Added value  -158.4 -9.8 88.1 -40.8 130.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  23 205 -88 -215 -190  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 -1.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.8% 663.4% 4.3% 296.8% 67.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -79.3% -14.9% 0.6% -21.3% 20.8%  
ROI %  -546.7% -31.2% 1.0% -44.7% 100.7%  
ROE %  -196.1% -25.2% 0.5% -38.2% 56.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -59.5% -28.4% -27.6% -65.1% -63.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2.9% -3,339.5% 233.9% -369.9% -99.1%  
Gearing %  -24.4% -203.5% -205.9% -54.1% -2.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.9% 2.8% 0.4% 0.8% 3.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.1 0.3 0.0 0.4  
Current Ratio  0.3 0.3 0.3 0.0 0.4  
Cash and cash equivalent  24.6 60.7 182.0 16.0 134.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -143.9 -475.3 -468.8 -466.0 -232.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0